Page 5 - Wolfe Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fullerton Fund Management Co Ltd. bought a new stake in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 6,617 shares of the construction company’s stock, valued at approximately $3,301,000. Other institutional investors and hedge funds […]

Fullerton Fund Management Co Ltd. bought a new stake in Martin Marietta Materials, Inc. (NYSE:MLM – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 6,617 shares of the construction company’s stock, valued at approximately $3,301,000. Other institutional investors and hedge funds […]

Frazier Life Sciences Management L.P. lifted its holdings in Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) by 4.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,131,008 shares of the biotechnology company’s stock after buying an additional 145,251 shares during the quarter. Alpine […]

Roper Technologies, Inc. (NYSE:ROP – Get Free Report) announced a quarterly dividend on Thursday, June 13th, Wall Street Journal reports. Stockholders of record on Monday, July 8th will be paid a dividend of 0.75 per share by the industrial products company on Monday, July 22nd. This represents a $3.00 dividend on an annualized basis and […]

Wolfe Research's latest analysis of 3M Company (NYSE:MMM) marked a significant upgrade in the company's outlook, shifting the rating from "Peer Perform" to "Outperform" and establishing a robust year-end 2024 price target of $125 per share.